Introduction {#s1}
============

*NGLY1* (*N*-glycanase 1) encodes an evolutionarily conserved enzyme that catalyzes the cleavage of *N*-glycans from glycoproteins ([@bib68]). Whole-genome and -exome sequencing has recently resulted in the identification of *NGLY1* mutations in patients with an autosomal recessive developmental disorder called NGLY1 deficiency ([@bib15]; [@bib22]; [@bib29]; [@bib49]). NGLY1-deficient patients show a host of phenotypes including global developmental delay, movement disorder, hypotonia, absent tears, peripheral neuropathy, constipation, and small feet and hands ([@bib22]; [@bib39]). The mechanism by which NGLY1 deficiency causes the above-mentioned clinical phenotypes is not known, and neither has NGLY1 been linked to any major developmental signaling pathway.

In yeast, *N*-glycanase 1 (Peptide: *N-*glycanase or PNGase, encoded by *PNG1*) has been associated with endoplasmic reticulum-associated degradation (ERAD) ([@bib69]; [@bib70]), a process that plays a crucial role in the proteasome-mediated degradation of misfolded proteins ([@bib13]; [@bib63]). However, null mutants for yeast *PNG1* do not show apparent phenotypic abnormalities and exhibit normal growth rate and viability under a variety of experimental conditions ([@bib68]). A recent study has provided strong evidence that in *C. elegans*, a transcription factor called SKN-1 (homolog to mammalian NFE2L1/2) needs to be retrotranslocated from ER to cytoplasm by ERAD machinery and deglycosylated by NGLY1 (PNG-1 in worms) to function properly ([@bib40]). However, deglycosylation does not result in SKN-1 degradation, but instead promotes the activation of SKN-1 so that it can mediate the necessary transcriptional response to proteasome disruption ([@bib40]). Moreover, mouse embryonic fibroblasts lacking NGLY1 did not show impairment and/or delay in the degradation of misfolded proteins, but displayed an unconventional deglycosylation reaction that may generate aggregation-prone proteins harboring *N*-GlcNAc and result in cell toxicity in the absence of NGLY1 ([@bib33]). Therefore, although NGLY1 seems to be functionally associated with the ERAD machinery, it does not seem to directly promote the degradation of misfolded proteins in animals.

Human *NGLY1* has a single *Drosophila* homolog called PNGase-like (*Pngl*), whose loss-of-function mutants result in semi-lethality and sterility ([@bib23]). We have used *Drosophila* to determine the molecular mechanisms by which *Pngl* regulates animal development. Our data indicate that *Pngl* is required in the visceral mesoderm (VM) during midgut development to regulate bone morphogenetic protein (BMP) signaling from VM to endoderm in embryonic midgut and also to ensure midgut clearance before puparium formation. BMP ligands can signal either as homodimers or as heterodimers through homodimeric or heterodimeric BMP type I receptors ([@bib7]; [@bib57]). Our data indicate that loss of *Pngl* abolishes a BMP autoregulatory loop in the VM mediated by homodimers of one ligand (Decapentaplegic; Dpp) acting through homodimers of one receptor (Thickveins; Tkv), and hence link a deglycosylation enzyme to tissue-specific regulation of BMP signaling in flies.

Results {#s2}
=======

A high level of functional conservation exists between fly Pngl and human NGLY1 {#s2-1}
-------------------------------------------------------------------------------

Based on the analysis of three *Pngl* alleles (*Pngl^ex14^*, *Pngl^ex18^* and *Pngl^ex20^*; [Figure 1A](#fig1){ref-type="fig"}), it has previously been reported that loss of *Drosophila Pngl* results in developmental delay and a semi-lethality phenotype, with about 1% adult escapers ([@bib23]). Moreover, these phenotypes were rescued by ubiquitous expression of mouse NGLY1 ([@bib23]), suggesting functional conservation between Pngl and its mouse homolog. To further examine the degree of conservation between fly Pngl and its mammalian homologs, we used ΦC31-mediated transgenesis ([@bib10]; [@bib76]) to generate transgenic flies capable of overexpressing wild-type (WT) human NGLY1 or the NGLY1-ΔR402 mutant, a single amino acid in-frame deletion identified in an NGLY1 deficiency patient ([@bib22]), and asked whether they can rescue the homozygous lethality of *Pngl^ex14^* and *Pngl^ex18^*. Ubiquitous expression of WT human NGLY1, but not NGLY1-ΔR402, was able to rescue the lethality in both *Pngl* alleles ([Figure 1B](#fig1){ref-type="fig"}). Both male and female *Pngl^--/--^* escaper flies are sterile and short-lived ([Figure 1C and D](#fig1){ref-type="fig"}) ([@bib23]). However, adult *Pngl^--/--^; Act \> NGLY1* WT animals do not show these phenotypes ([Figure 1C and D](#fig1){ref-type="fig"}). Together, these results underscore the *in vivo* functional homology between *Pngl* and *NGLY1*.

![Fly Pngl has a high level of functional conservation with human NGLY1.\
(**A**) Schematic of the *Pngl* locus and the deleted section of the alleles used in this study. (**B**) Eclosion tests of *Pngl^--/--^* flies with or without rescue by ubiquitous expression of NGLY1-WT or NGLY1-ΔR402. The red dashed line marks the expected Mendelian ratio. (**C**) Fertility tests of *Pngl^--/--^* flies rescued by NGLY1-WT and *Pngl^--/--^* escaper flies compared to yellow white (*y w*) flies used as control. (**D**) Longevity tests of *Pngl^--/--^* escaper flies compared to *Pngl^+/--^* and *Pngl^--/--^* flies rescued by NGLY1-WT. (**E**) RTL spotting assay on *png1Δ* mutant yeast transfected with empty vector or expression vectors for HA-tagged versions of *Saccharomyces cerevisiae* PNGase (Sc-Png1-HA), and wild-type or C303A-mutant *Drosophila* Pngl (Pngl-HA). (**F**) Western blot analysis of the yeast strains used in (**E**) by anti-HA antibody. (**G**) Cycloheximide (CHX) decay assay for FLAG-RTAΔ on yeast transfected with the same vectors as (**E**), followed by immunoblotting with anti-FLAG. Phosphoglycerate kinase (Pgk1) was used as loading control. (**H**) Quantification of cycloheximide decay assay for FLAG-RTAΔ showing deglycosylated (g0)/deglycosylated (g0) +glycosylated (g1) ratio for each genotype over time. The graph represents the mean of three independent experiments. (**I**) RTL spotting assay by using yeast PNGase (Sc-Png1-HA), and WT, C309A or ΔR402-mutant human NGLY1.](elife-27612-fig1){#fig1}

A previous study did not detect PNGase activity in wild-type *Drosophila* larval extracts in an *in vitro* assay using ^14^C-labeled asialofetuin glycopeptide as a substrate and concluded that *Drosophila* Pngl might not possess *N*-glycanase activity ([@bib23]). To better assess whether Pngl can function as an *N*-glycanase, we used RTL (RTAΔ-transmembrane-Leu2) spotting assays, which provide a reproducible *in vivo* model to assess the level of PNGase activity in yeast ([@bib32]). RTL undergoes ERAD in a PNGase-mediated, deglycosylation-dependent manner and therefore leucine-auxotrophic yeast cells which express functional *Saccharomyces cerevisiae* PNGase (Sc-Png1) are unable to grow in media lacking leucine. However, yeast cells that lack Sc-Png1 or express a catalytically-inactive version of Sc-Png1 fail to degrade RTL and can therefore grow on leucine-deficient medium ([@bib32]). As shown in [Figure 1E](#fig1){ref-type="fig"}, *png1* mutant yeast cells (*png1*Δ) grow well in media with or without leucine when transfected with the RTL plasmid. Expression of Sc-Png1-HA severely decreases the ability of these cells to grow in the absence of leucine, confirming that this phenotype is PNGase-dependent ([Figure 1E](#fig1){ref-type="fig"}) ([@bib32]). An HA-tagged version of the fly Pngl suppressed the growth of the yeast cell in media without leucine to the same extent as the Sc-Png1 ([Figure 1E](#fig1){ref-type="fig"}). Meanwhile, Pngl harboring a C303A mutation in its putative catalytic domain (Pngl-HA-C303A) failed to rescue PNGase function ([Figure 1E](#fig1){ref-type="fig"}), even though WT and C303A versions are expressed at comparable levels ([Figure 1F](#fig1){ref-type="fig"}). These observations strongly suggest that *Drosophila* Pngl is able to deglycosylate RTL and facilitate the efficient degradation of the RTL protein. Next, we expressed a FLAG-tagged version of RTAΔ in yeast cells and asked whether Pngl can increase the level of the deglycosylated version of this protein upon inhibition of the protein biosynthesis. In *png1*Δ mutant yeast cells, almost all RTAΔ was found to be in the glycosylated form (g1) at three time points ([Figure 1G](#fig1){ref-type="fig"}). Expression of Sc-Png1 or fly Pngl increased the relative level of the deglycosylated form (g0) in a time-dependent manner ([Figure 1G and H](#fig1){ref-type="fig"}). However, Pngl-C303A failed to remove glycans from RTAΔ. Similar experiments indicate that human NGLY1, but not the C309A catalytic mutant NGLY1, can also compensate for the lack of Sc-Png1 in the RTL assay ([Figure 1I](#fig1){ref-type="fig"}). Of note, NGLY1-ΔR402 showed a weak rescue of the PNGase activity in this assay, suggesting that it is a hypomorphic allele. Altogether, these observations indicate that *Drosophila* Pngl is indeed an *N*-glycanase enzyme and that there is high level of functional conservation between Pngl and its yeast and human homologs.

Loss of *Pngl* causes gastric caeca and acidification defects in the larval midgut {#s2-2}
----------------------------------------------------------------------------------

*Pngl^--/--^* larvae did not show any gross morphological defects. However, inspection of the larval internal organs suggested defects in the mutant larval midguts. In the anterior part of the midgut, control larvae harbor four finger-like structures called gastric caeca ([Figure 2A and B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), which play key roles in the insect digestive system, including water and ion transport and secretion of enzymes ([@bib56]; [@bib77]). *Pngl^--/--^* larvae showed a severe shortening of the gastric caeca ([Figure 2C](#fig2){ref-type="fig"}, red asterisks) compared to *y w* and heterozygote controls ([Figure 2B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Control larvae harbor a specific region in the middle midgut called the 'acid zone', which has a luminal pH of less than 2.3 and is considered the fly stomach ([Figure 2A](#fig2){ref-type="fig"}) ([@bib21]). The acid zone can be visualized by feeding larvae with bromophenol blue (BPB), which is blue in neutral and basic pH but turns yellow as the pH is decreased from 7.0 to 1.0 ([Figure 2D](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, red dotted box). *Pngl^--/--^* larvae are almost completely devoid of the yellow color in the midgut, indicating a loss of acid zone ([Figure 2E](#fig2){ref-type="fig"}). Similar to *Pngl^ex14/ex14^* larvae, *Pngl^ex18/ex18^* and *Pngl^ex20/ex20^* animals showed shortened gastric caeca and a loss of acid zone ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} and not shown). Moreover, *Pngl^ex14^* and *Pngl^ex18^* hemizygous animals (over a deficiency allele) showed semi-lethality and midgut phenotypes ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} and not shown), suggesting that *ex14* and *ex18* deletions are genetic null alleles. Altogether, these data indicate that loss of *Pngl* leads to specific midgut defects in *Drosophila* larvae.

![Loss of *Pngl* results in larval midgut defects and impaired BMP signaling from VM to endoderm.\
(**A**) Schematic drawing of larval midgut/hindgut indicating gastric caeca (GC), anterior midgut (AM), middle midgut (MM), posterior midgut (PM), and hindgut (HG). (**B and C**) Bright field images of the proximal midgut region of larvae 96 hours after egg deposition. Red asterisks in C mark the shortened gastric caeca upon loss of *Pngl*. Scale bar, 100 µm. (**D and E**) Bright field images of midgut from third instar larvae fed with food containing bromophenol blue. Acid zone is delimitated by the red dotted boxes. Scale bar, 100 µm. (**F**) Schematic drawing of Dpp signaling in the embryonic midgut. (**G--H'**) pMad staining of stage 14 embryos of the indicated genotypes. In G and H, limited projection views are shown to highlight pMad expression in PS3 (arrow) and PS7 (arrowhead). G' and H' are full projection view of the datasets shown in G and H. Note that expression of pMad in ectodermal bands and other regions are not affected by the loss of *Pngl* (double-arrowheads). (**I--L'**) Fas3 (VM marker) and Labial staining of stage 15 and 16 embryos of indicated genotypes. Midgut constrictions are marked by numbers along the anterior-posterior axis.](elife-27612-fig2){#fig2}

BMP signaling from VM to endoderm is impaired upon loss of *Pngl* {#s2-3}
-----------------------------------------------------------------

In *Drosophila* embryos, a member of the bone morphogenetic protein (BMP) family called Decapentaplegic (Dpp) signals from VM to endoderm and is required for midgut specification ([@bib21]; [@bib55]). Specifically, BMP signaling from VM in parasegment 3 (PS3) and PS7 is transduced by phosphorylated Mothers against dpp (pMad) ([@bib52]) in midgut endoderm, resulting in the formation of the gastric caeca and the acid zone, respectively ([Figure 2F](#fig2){ref-type="fig"}). Given the striking similarity between *Pngl* midgut phenotypes and those caused by impaired BMP signaling from VM ([@bib55]), we examined the effects of loss of *Pngl* on BMP signaling by staining *Drosophila* embryos with an antibody against human pSMAD3, which recognizes *Drosophila* pMad ([@bib42]). Control embryos (*y w* and *Pngl^+/--^*) showed pMad staining in areas corresponding to PS3 and PS7 ([Figure 2G and G'](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). However, *Pngl^--/--^* embryos showed a dramatic decrease in the level of pMad in PS3 and PS7 ([Figure 2H and H'](#fig2){ref-type="fig"}). Notably, pMad staining in other regions of the embryos, including the ectodermal and head regions, was not affected by the loss of *Pngl* ([Figure 2H'](#fig2){ref-type="fig"}, compare to [Figure 2G'](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Loss of BMP signaling in PS7 results in lack of second midgut constriction and impairs the expression of the acid-secreting (copper) cell-specific homeodomain gene *labial* in PS7 endodermal cells ([@bib35]; [@bib50]; [@bib55]). We used anti-Labial antibody to mark the precursors of the midgut copper cells in the embryonic endoderm and anti-Fas3 (Fasciclin 3) antibody to mark VM ([@bib79]) and to visualize midgut constrictions and chambers. As reported previously ([@bib50]), at stage 15, control embryos show a prominent second midgut constriction and Labial expression anterior to it ([Figure 2I and I'](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). However, in stage 15 *Pngl^--/--^* embryos, no Labial signal was detectable in the PS7 region ([Figure 2J and J'](#fig2){ref-type="fig"}). By stage 16, all three constrictions are clearly visible in control larvae and Labial is expressed in the midgut compartment between first and second constrictions ([Figure 2K and K'](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). However, stage 16 *Pngl^--/--^* embryos lack Labial staining and second constriction ([Figure 2L and L'](#fig2){ref-type="fig"}), in agreement with impaired BMP signaling in PS7. Together, these data demonstrate that *Pngl* is required for mesoderm-to-endoderm BMP signaling in *Drosophila* embryos.

*Pngl* is primarily required in the mesoderm during *Drosophila* development, but not all *Pngl* phenotypes can be explained by impaired Dpp signaling {#s2-4}
------------------------------------------------------------------------------------------------------------------------------------------------------

To determine which tissues or cell types require the function of Pngl, we performed RNAi-mediated knock-down (KD) and rescue experiments. When crossed to the mesodermal driver *Mef2-GAL4*, the *Pngl^RNAi^* KK101641 strain (<http://stockcenter.vdrc.at/control/main>) resulted in 100% lethality at room temperature and recapitulated the gastric caeca shortening and acid zone loss phenotypes observed in *Pngl* mutants ([Figure 3A--C](#fig3){ref-type="fig"}). In addition, *Pngl* KD by another mesodermal driver called *how^24B^-GAL4* resulted in partial lethality and acid zone defects in larvae ([Figure 3A and E](#fig3){ref-type="fig"}). *Pngl* KD with *how^24B^-GAL4* did not affect gastric caeca formation ([Figure 3D](#fig3){ref-type="fig"}), likely because this driver induces transgene expression later than *Mef2-GAL4* ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), after gastric caeca anlagen have already been formed. However, *Pngl* KD by two endodermal drivers did not result in lethality and gut phenotypes ([Figure 3A and F--I](#fig3){ref-type="fig"}). Moreover, overexpression of human *NGLY1* with *Mef2-GAL4* and *how^24B^-GAL4* rescued the lethality of the *Pngl* alleles ([Figure 3J](#fig3){ref-type="fig"}). In agreement with the severity of their corresponding KD phenotypes and expression patterns, *Mef2-GAL4* rescued the lethality more efficiently than *how^24B^-GAL4* ([Figure 3J](#fig3){ref-type="fig"}). Together, these data indicate that during *Drosophila* development Pngl is primarily required in the mesoderm to ensure animal survival and to promote BMP signaling from visceral mesoderm to endoderm.

![The enzymatic activity of Pngl is essential in the mesoderm for the regulation of BMP pathway in the midgut.\
(**A**) Eclosion tests of *Pngl^RNAi^* flies based on expected Mendelian ratio using two pan-mesodermal drivers (*Mef2-* and *how^24B^-GAL4*) and two midgut endodermal drivers (*NP3207-* and *NP3270-GAL4*). (**B--I**) Proximal midgut region and acid zone of the indicated genotypes. (**J**) Rescue of the lethality of *Pngl^ex14/ex144^* animals by expressing NGLY1-WT using *Mef2- and how^24B^-GAL4* drivers. (**K--N**) Proximal midgut region and acid zone of the indicated genotypes. (**O**) SDS gels were used to run larval extracts from the indicated genotypes and were probed with an antibody against Pngl. (**P**) Eclosion tests of *dpp^RNAi^* flies using *Mef2-* and *how^24B^-GAL4* drivers. (**Q--T**) Proximal midgut region and acid zone of the indicated genotypes.](elife-27612-fig3){#fig3}

It was previously shown that a *Pngl* transgene harboring the C303A mutation in the catalytic domain ([Figure 1E and G](#fig1){ref-type="fig"}) is not able to rescue the lethality of *Pngl* mutants ([@bib23]). To test whether the enzymatic activity of Pngl is required for the regulation of BMP signaling in the midgut, we overexpressed *Pngl-C303A* by *Mef2-GAL4* in *Pngl* mutants. As shown in [Figure 3K and L](#fig3){ref-type="fig"}, overexpression of wild-type *Pngl* rescues gastric caeca and acid zone defects of *Pngl* mutants. However, the mutant version fails to rescue *Pngl* midgut phenotypes ([Figure 3M and N](#fig3){ref-type="fig"}), even though Western blot shows that this mutation does not affect the expression level or stability of Pngl ([Figure 3O](#fig3){ref-type="fig"}). Together, these data indicate that the BMP signaling impairment observed in *Pngl* larval midguts is due to the lack of Pngl's enzymatic activity.

Previous reports indicate that in the absence of midgut acidification, larvae are able to reach adulthood ([@bib20]). Moreover, regulatory mutations that result in specific loss of *dpp* expression in PS3 and a complete loss of gastric caeca only show a partial lethality ([@bib46]). Accordingly, impaired Dpp signaling in the midgut is not sufficient to fully explain the lethality of *Pngl* mutants, especially given that gastric caeca are not completely lost. Indeed, animals undergoing *dpp* KD by the same mesodermal drivers showed a higher survival compared to those undergoing *Pngl* KD ([Figure 3P](#fig3){ref-type="fig"}, compare to 3A). Specifically, *Mef2 \> Pngl^RNAi^* and *how^24B^ \> Pngl^RNAi^* animals showed 0% and \~28% survival rate into adulthood, but *Mef2 \> dpp^RNAi^* and *how^24B^ \> dpp^RNAi^* animals showed \~8% and \~80% survival rate into adulthood, respectively. The weaker effects of *dpp^RNAi^* are not likely to result from inefficient *dpp* KD, as *Mef2 \> dpp^RNAi^* larvae exhibited a complete loss of gastric caeca and acid zone, and *how^24B^ \> dpp^RNAi^* larvae lost the acid zone but not the gastric caeca, suggesting a loss or severe impairment of mesoderm-to-endoderm BMP signaling corresponding to the spatiotemporal expression pattern of each driver ([Figure 3Q--T](#fig3){ref-type="fig"}). These observations indicate that impaired Dpp signaling in the midgut can only partially account for the lethality observed in *Pngl* mutants.

So far our data suggest that Pngl also plays a Dpp-independent role in the mesoderm during *Drosophila* development. We noticed that during the wandering phase, *Pngl^--/--^* larvae failed to empty their guts ([Figure 4A and A'](#fig4){ref-type="fig"}). To better characterize this phenotype, we carried out midgut clearance assays. When larvae are raised on regular food supplemented with bromophenol blue (BPB), they show a dark blue gut approximately 24--48 hours before puparium formation (early L3 stage). At late L3 stage, they stop eating and enter the wandering stage, during which they empty their gut and reach the stationary stage ([@bib18]). *Pngl^+/--^* (control) and *Pngl^--/--^* larvae both exhibit a blue gut during early L3 stage, indicative of eating food containing BPB ([Figure 4B](#fig4){ref-type="fig"}). Once taken off the BPB food during the wandering stage, control larvae gradually lose the blue color and pupariate, but the *Pngl^--/--^* larvae fail to empty their guts and exhibit a delay in pupariation ([Figure 4B](#fig4){ref-type="fig"}). Control *y w* and *Pngl^+/--^* larvae typically emptied their gut in 6 hours and reached the pre-pupal stage ([Figure 4C](#fig4){ref-type="fig"}). In contrast, most *Pngl^--/--^* larvae showed a blue gut throughout the wandering stage ([Figure 4C](#fig4){ref-type="fig"}). Indeed, even 24--48 hours later, more than 50% of the *Pngl^+/--^* animals were still in the larval stage and retained the blue food in their abdomens. These data indicate that loss of *Pngl* causes an impairment of gut clearance at late L3 stage.

![Loss of *Pngl* in the mesoderm causes food accumulation in larval midgut.\
(**A--A'**) Wandering larvae of *Pngl^ex14/+^* with a GFP^+^ balancer chromosome for selection \[*--/*GFP\] and *Pngl^ex14/ex14^* GFP*^--^* larvae \[*--/--*\] showing food accumulation. (**B**) Gut clearance assay in larval stages using Bromophenol blue (BPB) as a marker. The top part shows the timeline of BPB feeding during development. At the bottom, representative images of *Pngl^ex14/+^* \[*+/--*\] and *Pngl^ex14/ex14^* larvae \[*--/--*\] at different times and stages are shown. (**C--E**) Quantification of midgut clearance assays in third instar larvae of the indicated genotypes.](elife-27612-fig4){#fig4}

To examine whether impaired BMP signaling can also explain the food accumulation phenotype observed upon loss of *Pngl*, we compared the *dpp* and *Pngl* KD phenotypes by the same mesodermal drivers. BPB feeding assays showed that *Mef2 \> dpp^RNAi^* larvae exhibit a food accumulation phenotype milder than that observed in *Pngl* mutant and *Mef2 \> Pngl^RNAi^* larvae, and that *how^24B^ \> dpp^RNAi^* larvae do not exhibit any food accumulation phenotype, in contrast to *how^24B^ \> Pngl^RNAi^* animals ([Figure 4D](#fig4){ref-type="fig"}, compare to [Figure 4E](#fig4){ref-type="fig"}). These data indicate that the food accumulation phenotype observed in *Pngl* mutants is at least in part independent of impaired BMP signaling.

Pngl is required for proper Dpp propagation and autoactivation in the embryonic VM {#s2-5}
----------------------------------------------------------------------------------

Loss of *Pngl* affects BMP signaling in the midgut but not in the ectodermal regions of the *Drosophila* embryos. To shed light on the mechanism by which *Pngl* regulates BMP signaling in a tissue-specific manner, we stained *Pngl* mutant and control embryos with a polyclonal anti-Dpp antibody raised against its prodomain ([@bib2]). In WT and *Pngl^+/-- ^*embryos at stage 13, the Dpp protein is expressed in ectodermal bands, several regions in the anterior part of the embryo and two rather narrow groups of cells corresponding to PS3 and PS7, where it shows a punctate pattern superimposed on a diffuse signal ([Figure 5A, B, G and H](#fig5){ref-type="fig"}). Overall, the staining is somewhat weaker in *Pngl^--/--^* embryos, but staining in PS3 and PS7 is observed, with a notable decrease in puncta ([Figure 5C and I](#fig5){ref-type="fig"}). By stage 14, a broad and strong Dpp expression domain can be observed in PS3 and PS7 in control embryos ([Figure 5D, E, J and K](#fig5){ref-type="fig"}). In contrast, Dpp expression in the VM remains weak and narrow in PS3 and PS7 of mutant embryos ([Figure 5F and L](#fig5){ref-type="fig"}). Notably, the pattern of Dpp expression in the ectoderm is similar in control and *Pngl^--/--^* embryos at both stages, even though the staining seems to be slightly weaker in mutant embryos ([Figure 5A--F](#fig5){ref-type="fig"}). These results suggest that a failure to expand the Dpp expression domain in the VM leads to impaired mesoderm-to-endoderm BMP signaling in *Pngl* mutants.

![*Pngl* is required for proper Dpp propagation and autoactivation in the embryonic VM.\
(**A--F**) Projection views of Dpp staining for stage 13 (**A--C**) and stage 14 (**D--F**) embryos of the indicated genotypes are shown. Arrows and arrowheads mark PS3 and PS7, respectively. Scale bar in A is 100 µm. (**G--N**) Dpp staining in PS7. Limited projection views for stages 13 (**G--I and M**) and 14 (**J--L and N**) embryos of the indicated genotypes are shown. (**O--P'**) pMad staining of PS7 at stages 13 (**O--O'**) and 14 (**P--P'**). Green marks mesoderm (*Mef2 \>GFP*). (**Q**) Schematic drawing of Dpp autoactivation in PS7 in stages 13 and 14. (**R--U'**) Limited projection views of PS7 for the indicated genotypes at embryonic stages 13 and 14. *dpp-lacZ* is marked in green (gray in R'-U'), red marks pMad.](elife-27612-fig5){#fig5}

Given the weaker Dpp staining in stage 13 *Pngl* mutant embryos, we asked whether the failure to expand the Dpp expression domain and loss of BMP signaling in the embryonic midgut of *Pngl* mutants is simply due to reduction of *dpp* expression in the mesoderm. To address this point, we used the *dpp^S2^* allele, which harbors a chromosomal breakpoint in the regulatory elements that control *dpp* expression in digestive tract ([@bib46]). Embryos heterozygous for this allele exhibit a decrease in Dpp expression at stage 13 in PS7, even compared to *Pngl^--/--^* embryos ([Figure 5M](#fig5){ref-type="fig"}, compare to [Figure 5G, H and I](#fig5){ref-type="fig"}). Nevertheless, these embryos show Dpp propagation at stage 14 and proper Dpp signaling from mesoderm to endoderm, as evidenced by analyzing the expression of Dpp targets in the embryonic midgut and gastric caeca and acid zone in larvae ([Figure 5N](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). These data suggest that decreased Dpp expression by itself cannot explain the impaired Dpp propagation and loss of mesoderm-to-endoderm BMP signaling in *Pngl* mutants.

To understand how Dpp spreads in PS7 during embryonic midgut development, we expressed *UAS-GFP* in embryonic mesoderm by *Mef2-GAL4* driver and stained embryos for pMad at stage 13 and 14. At stage 13 the majority of pMad staining is localized to the VM and only a few cells are stained in the endoderm ([Figure 5O and O'](#fig5){ref-type="fig"}). Later at stage 14, BMP signaling spreads through the endoderm and expands in PS7, as evidenced by the presence of many pMad-positive endodermal cells ([Figure 5P and P'](#fig5){ref-type="fig"}; GFP*^--^*, round nuclei). These observations are in agreement with previous reports suggesting the existence of an autoregulatory Dpp para-autocrine loop in PS7, which acts through *Ultrabithorax* (*Ubx*) expression in VM and results in maintenance and accumulation of Dpp expression in VM cells ([Figure 5Q](#fig5){ref-type="fig"}) ([@bib9]; [@bib34]; [@bib65]). To test whether Pngl affects Dpp autoactivation in VM, we used a *dpp* enhancer trap line and stained embryos for pMad and βGAL. In *Pngl^+/--^* embryos at stage 13, we found a row of cells co-expressing pMad and βGAL ([Figure 5R--R'](#fig5){ref-type="fig"}), suggesting para-autocrine activation. In PS7 of *Pngl^--/--^* embryos at stage 13, *dpp-lacZ* expression can be detected, but pMad staining is absent ([Figure 5S--S'](#fig5){ref-type="fig"}). These results indicate that in *Pngl^--/--^* PS7, the initial, Ubx-dependent *dpp* expression ([@bib67]) occurs, but the autoactivation loop is impaired. At stage 14, the Dpp expression domain expands in *Pngl^+/--^* embryos and *dpp-lacZ* expressing cells can be seen in multiple layers. Most if not all *dpp-lacZ* expressing cells still co-express pMad, likely due to autoactivation, while endodermal cells, as receiving cells, only express pMad ([Figure 5T--T'](#fig5){ref-type="fig"}). In stage 14 *Pngl^--/--^* embryos, *dpp-lacZ*-expressing cells remain confined to their initial narrow domain in PS7, and pMad staining is still not detectable ([Figure 5U--U'](#fig5){ref-type="fig"}). This is in contrast to the dorsal ectodermal region, which showed a comparable expression pattern and intensity in the dorsal ectodermal bands of *Pngl^+/--^* and *Pngl^--/--^* embryos for both *dpp-lacZ* and pMad ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Altogether, these data indicate that *Pngl* is not required for the initial expression of *dpp* through *Ubx* in *Drosophila* embryos but is required for the autoregulatory role of Dpp in the VM.

Loss of BMP signaling in *Pngl^--/--^* embryonic endoderm is caused by impaired BMP autoactivation in VM {#s2-6}
--------------------------------------------------------------------------------------------------------

We next asked whether bypassing the BMP autoactivation loop by mesodermal overexpression of a GFP-tagged version of Dpp ([@bib73]) can rescue *Pngl* phenotypes in embryos. In control animals, *dpp-GFP* overexpression by *Mef2-GAL4* resulted in broad pMad staining in embryonic midgut and ectopic pMad expression throughout the ectoderm ([Figure 6A and D](#fig6){ref-type="fig"}). Dpp-GFP protein can be seen by GFP staining and shows a continuous pattern going through PS3 to PS7 ([Figure 6D'](#fig6){ref-type="fig"}). In *Pngl^--/--^* embryos, mesodermal expression of Dpp-GFP restored pMad expression in PS3 and PS7, indicating a rescue of BMP signaling from VM to endoderm ([Figure 6B and E](#fig6){ref-type="fig"}, compare to [Figure 6C and F](#fig6){ref-type="fig"}). Notably, in *Pngl^--/--^; Mef2 \> dpp* GFP embryos, pMad staining was limited to PS3 and PS7, and ectopic pMad expression in the ectoderm was almost completely suppressed ([Figure 6B and E](#fig6){ref-type="fig"}), indicating that loss of *Pngl* dramatically decreases the ability of mesodermally-expressed Dpp-GFP to induce ectopic BMP signaling.

![Dpp-GFP and Tkv^CA^ overexpression in mesoderm rescues Dpp signaling in *Pngl^--/--^* embryo.\
(**A--C**) Projection views of stage 14 embryos of the indicated genotypes stained with anti-pMad (red) and anti-GFP (green) antibodies. (**D--F'**) Close-ups of embryonic PS3 and PS7 of indicated genotypes. Notably, in the *Pngl^--/--^* embryo, *Mef2 \>dpp* GFP overexpression rescues pMad staining in PS3 and PS7 (E, compared to F). (**G--H'**) Close-ups of embryonic PS3 and PS7 of indicated genotypes. pMad is marked in red and Fas3 in green. Arrows mark pMad staining outside of PS7. (**I**) Eclosion tests of the indicated genotypes. The red dashed line marks the expected Mendelian ratio.](elife-27612-fig6){#fig6}

If BMP autoactivation is impaired in *Pngl^--/--^* VM, bypassing the normal autoactivation process by expressing a constitutively active form of the BMP receptor Tkv (*tkv^CA^*) in the mesoderm should restore BMP signaling in the PS3 and PS7 endoderm. *Mef2 \> tkv^CA^* embryos exhibited proper pMad staining in PS3 and PS7 in a *Pngl^+/+^* background, although some pMad staining outside of PS7 could be seen in the VM marked by Fas3 ([Figure 6G and G'](#fig6){ref-type="fig"}, arrows). When *tkv^CA^* is overexpressed in *Pngl^--/--^* embryonic mesoderm, pMad was restored in PS3 and PS7 and still some extra pMad positive cells were detected ([Figure 6H and H'](#fig6){ref-type="fig"}, arrows). Moreover, \~30% of *Pngl^--/--^; Mef2 \> tkv^CA^* animals reach adulthood ([Figure 6I](#fig6){ref-type="fig"}). These observations further indicate that impaired BMP signaling is partially responsible for the lethality of *Pngl^--/--^* animals. This is likely due to gastric caeca shortening ([@bib46]), although we cannot exclude that *tkvCA* overexpression affects unknown BMP-related defects in other parts of mesoderm in these mutants. We note that the rescued *Pngl^--/--^; Mef2 \> tkv^CA^* adults did not show the acid zone loss and midgut shortening phenotypes observed in *Pngl^--/--^* adult escapers ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). This indicates that the BMP-related midgut phenotypes of *Pngl* mutants persist to adulthood. Altogether, these results support the notion that BMP signaling in VM requires an autoregulatory step to reach the required threshold for signaling to endoderm and that this is the step during midgut development that is impaired in *Pngl* mutants. The data also indicate that this developmental defect contributes to the semi-lethality of *Pngl* mutants.

BMP autoactivation in VM is mediated by Dpp and Tkv homodimers {#s2-7}
--------------------------------------------------------------

BMPs can function as homodimers or heterodimers to signal through homo- and/or heterodimeric type I receptors ([@bib30]; [@bib53]). To date, three BMP ligands have been identified in *Drosophila: dpp*, *glass bottom boat* (*gbb*) and *screw* (*scw*) ([@bib6]; [@bib19]; [@bib54]; [@bib80]). *scw* is required in early embryogenesis, where it acts in combination with *dpp* to specify dorsal cells fates ([@bib6]). *gbb* and *dpp* mutants have both distinct and overlapping phenotypes during and after embryonic development, suggesting that *gbb* and *dpp* are required together for proper signaling in some developmental contexts ([@bib24]; [@bib28]; [@bib31]; [@bib37]; [@bib80]). To assess whether *gbb* is involved in BMP signaling and Dpp expression in embryonic midgut and the generation of *Pngl^--/--^* phenotypes, we performed Dpp and pMad staining in *gbb* mutant embryos at stage 14, focusing on PS3 and PS7. Unlike control embryos ([Figure 7A](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}), *gbb^D4/D20^* and *gbb^D4/D4^* embryos showed reduced pMad staining in PS3 ([Figure 7C](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}), in agreement with previous work indicating that gastric caeca are somewhat short in *gbb* mutant larvae ([@bib80]). However, in *gbb^--/--^* embryos pMad staining in PS7 is increased and shifts anteriorly towards PS3 ([Figure 7C](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). In *gbb^D4/D20^* embryos, the Dpp expression domain in PS3 is similar in size to that in control embryos ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). However, the Dpp expression domain in PS7 is broader and stronger than controls in these embryos and extends anteriorly to PS6, and additional Dpp-positive puncta can be detected outside of the acid zone region towards PS3 ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). At stage 16, *gbb^--/--^*embryos show an abnormal expansion of the second midgut compartment and a diffuse Labial staining both anteriorly and posteriorly to the second constriction ([Figure 7D and D'](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}) compared to controls ([Figure 7B and B'](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Therefore, *gbb* phenotypes in the midgut are quite different from *dpp* and *Pngl* loss-of-function phenotypes. The strong and broader than normal pMad expression domain in *gbb^--/--^* PS7 indicates that BMP signaling in this region is mediated by Dpp homodimers alone and Gbb likely limits the area in the VM wherein BMP autoactivation and signaling can occur.

![Pngl regulates Dpp homodimer level and signaling via Tkv receptor homodimers.\
(**A, C, E, G**) Close-ups of embryonic PS3 and PS7 of indicated genotypes. pMad is marked in red. (**B--B', D--D', F--F' and H--H'**) Fas3 (VM marker) and Labial staining of stage 16 embryos of indicated genotypes. Numbers indicate embryonic midgut constrictions. (**I**) Schematic representation of the Dpp protein dimer and its processing. (**J, K**) Reducing (**J**) and non-reducing (**K**) SDS gels were used to run larval extracts from the indicated genotypes and were probed with a polyclonal antibody against the Dpp prodomain.](elife-27612-fig7){#fig7}

In *Drosophila*, two type I receptors Tkv and Saxophone (Sax) and one type II receptor (Punt) are involved in BMP signaling ([@bib41]; [@bib50]; [@bib51]; [@bib59]). Given the differential roles of the Dpp versus Gbb ligands in BMP autoactivation in VM, we asked whether the contribution of Tkv and Sax to this process is also different from each other. As shown in [Figure 6E](#fig6){ref-type="fig"}, mesodermal knock-down of *tkv* results in a severe reduction of pMad staining in PS7 and a partial loss of pMad in PS3. Similar to *Pngl^--/--^* embryos, the Dpp expression domain in PS7 fails to expand in *Mef2 \> tkv^RNAi^* embryos, although *tkv* KD does not seem to affect the intensity of Dpp staining at stage 13 or the presence of Dpp-positive puncta ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). In *Mef2 \> sax^RNAi^* embryos, pMad staining in PS3 seems to be slightly decreased compared to controls, but it looks broader in PS7 and is extended anteriorly ([Figure 7G](#fig7){ref-type="fig"}). Furthermore, *Mef2 \> tkv^RNAi^* embryos show a lack of second constriction and loss of Labial in the PS7 region ([Figure 7F and F'](#fig7){ref-type="fig"}). In contrast, mesodermal knock-down of *sax* did not show evident midgut constriction defects, but aberrant Labial staining was detectable both anteriorly and posteriorly to the second constriction, similar to *gbb^--/--^* embryos ([Figure 7H and H'](#fig7){ref-type="fig"}). These results strongly suggest that BMP autoactivation in PS7 mesoderm is mediated by Dpp homodimers, as ligand, and Tkv homodimers, as receptor.

Similar to its vertebrate homologs, Dpp is synthetized as an inactive proprotein ([Figure 7I](#fig7){ref-type="fig"}). Following dimerization in the endoplasmic reticulum (ER), Dpp proprotein dimers traffic through the secretory pathway, where they undergo cleavages to release the active dimer ([@bib17]; [@bib38]; [@bib64]). Since our results indicate a role for *Pngl* in Dpp autoactivation mediated by Dpp homodimers (as opposed to Dpp-Gbb heterodimers) in PS7 VM, we examined the effects of loss of Pngl on Dpp dimerization and processing by Western blotting on larval extracts using the above-mentioned anti-Dpp antibody ([@bib2]). When ran on a reducing gel, control larvae (*y w* and *UAS-Pngl^RNAi^* without a GAL4 driver) exhibited two prominent bands: one corresponding in size to the full-length proprotein monomer and the other to the proprotein dimer, suggesting that Dpp dimers are partially resistant to the amount of reducing agents used in our assays ([Figure 7J](#fig7){ref-type="fig"}). A third band slightly bigger and much fainter than the proprotein monomer was also observed in control larvae ([Figure 6J](#fig6){ref-type="fig"}, red asterisk). Larvae homozygous for *Pngl* alleles and those ubiquitously expressing *Pngl* dsRNA showed an accumulation of a band corresponding in size to the prodomain (cleavage product) and a significant decrease in the intensity of the band corresponding to Dpp dimers, without an apparent decrease in the intensity of the proprotein monomer band ([Figure 7J](#fig7){ref-type="fig"}). Of note, although larvae heterozygous for the *Pngl^ex14^* allele did not show any midgut defects ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), they displayed an intermediate pattern in the Western blot, suggesting that Pngl plays a dosage-sensitive role in Dpp dimerization and/or processing ([Figure 7J](#fig7){ref-type="fig"}). To better assess the level of Dpp dimers in a *Pngl*-deficient background, we performed Western blot analysis on larval extracts ran on a non-reducing SDS gel electrophoresis ([Figure 7K](#fig7){ref-type="fig"}). Control larvae showed two rather strong bands corresponding in size to Dpp dimers and a weaker band corresponding to a proprotein monomer. This indicates that in a non-denaturing state, Dpp molecules are primarily found in association with other molecules and form Dpp-Dpp homodimers. We found a significant decrease in Dpp dimers in *Pngl* mutant and knock-down larvae and a corresponding increase in the level of full-length monomer and the same cleavage product observed in regular Western blots. Again, *Pngl^ex14/+^* larvae showed an intermediate band pattern, with a significant decrease in the intensity of one of the two 'dimer' bands and an apparent increase in the intensity of the full-length monomer ([Figure 7K](#fig7){ref-type="fig"}). Dpp dimers are not exclusively reduced in midguts of *Pngl* mutants but are also decreased in other parts of the larval body ([Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}). In summary, these data provide strong evidence that Pngl is required for the formation and/or the stability of Dpp dimers.

Discussion {#s3}
==========

The broad phenotypes of children affected with NGLY1 deficiency ([@bib22]; [@bib49]) and the semi-lethality of *Pngl^--/--^* flies ([@bib23]) indicate that NGLY1 plays important roles during animal development. However, the *N*-glycanase function has not been linked to any developmental signaling pathway. Here we report that fly *Pngl* regulates BMP signaling during embryonic midgut development without affecting BMP signaling in ectodermal and head regions of the embryo. Our data indicate that *Pngl* is not required in the midgut endoderm to receive the BMP signal, but rather is required in the VM to send the BMP signal. It has previously been shown that BMP signaling uses a paracrine/autocrine loop in the VM to sustain and increase the expression of Dpp in PS3 and PS7 of embryonic VM. This loop is proposed to ensure that the level of BMP ligands in the VM is high enough to induce signaling in the endoderm and to specify gastric caeca, the second midgut constriction and the acid zone ([@bib9]; [@bib34]; [@bib65]). Several lines of evidence indicate that the BMP autoregulation mediated by the para-autocrine loop in the VM is the step which is impaired in *Pngl*-deficient embryos. First, Pngl is not required for the initial, Ubx-dependent expression of *dpp*. In fact, even a 50% decrease in the expression of *dpp* in the visceral mesoderm of *dpp^s2/+^* animals does not impair BMP autoactivation and midgut development. Second, despite expressing Dpp at early stages, BMP signaling is not activated in *Pngl^--/--^* VM, as evidenced by the lack of pMad staining. Third, overexpression of Dpp-GFP in the mesoderm is able to induce BMP signaling in the endoderm in *Pngl^--/--^* embryos. Lastly, bypassing the para-autocrine loop by transgenic expression of a constitutively active BMP receptor in the mesoderm results in restoration of BMP signaling in PS3 and PS7 regions of the endoderm and in partial rescue of lethality in *Pngl^--/--^* embryos.

In the BMP para-autocrine loop, VM cells both secrete the BMP ligand and respond to it. Therefore, theoretically, Pngl might play a critical role in sending the BMP signal, receiving the BMP signal, or both. Although our data do not allow us to exclude any of these possibilities, based on the following observations, we favor a scenario in which Pngl is required in VM cells to send the Dpp signal not to receive it: (1) Pngl is not required to receive the BMP signal in the endoderm; (2) Loss of Pngl and *Pngl* KD result in a dramatic decrease in the level of Dpp homodimers and the Dpp-positive puncta; (3) Expression of a constitutively active form of Tkv in the mesoderm is able to restore midgut pMad staining in embryos and the copper cell region in the adult midgut, and partially rescue the lethality of *Pngl^--/--^* animals; (4) Loss of *Pngl* almost fully suppresses the aberrant BMP signaling caused by mesodermal overexpression of Dpp-GFP.

Whole larval protein extracts from *Pngl*-deficient animals show an increase in the level of the monomeric forms of Dpp (full-length and a cleavage product) and a simultaneous decrease in the bands corresponding in size to Dpp dimers. Moreover, *Pngl^--/--^* embryos show a decrease in Dpp-positive puncta both in the mesoderm, where signaling is impaired, and in the ectoderm, where signaling is not impaired. Together, these observations indicate that the effect of loss of Pngl on the Dpp protein itself is not limited to the mesoderm. Indeed, protein extracts from *Pngl*-deficient midgut and carcass (without midgut) both show a decrease in Dpp dimer levels. This suggests that either Pngl regulates BMP signaling by affecting Dpp dimer levels in other larval tissues not identified yet, or that Dpp dimers are only important in the midgut and although they are decreased elsewhere, Dpp-Gbb heterodimers compensate for the lack of Dpp dimers in most other tissues. Regardless, we propose that loss of BMP signaling in *Pngl* mutant midguts results from a requirement for Dpp homodimers in the para-autocrine autoregulatory loop present in the visceral mesoderm.

BMP ligands can signal both as homodimers and as heterodimers ([@bib11]; [@bib53]). *In vitro* and *in vivo* studies have shown that in general, BMP heterodimers have stronger bioactivity than their homodimers counterparts ([@bib5]; [@bib14]; [@bib36]; [@bib43]; [@bib48]; [@bib75]). In some cases, the homodimers induce weak to moderate signaling, and in other cases they either do not elicit signaling or even play an antagonistic role ([@bib8]; [@bib53]). Stronger activity of BMP heterodimers can at least in part be explained by differential affinities of individual BMP ligands for different BMP receptors, combined with stronger signal transduction by heterodimeric type I receptors compared to homodimers of each type I receptor. For example, in *Drosophila*, Dpp has a higher affinity for Tkv, whereas the other two ligands--Gbb and Scw--have a higher affinity for Sax ([@bib8]; [@bib53]; [@bib61]). A similar receptor-ligand binding preference has been observed among the vertebrate orthologs ([@bib4]; [@bib43]). In the embryonic dorsal midline and the wing imaginal disc, Dpp/Scw and Dpp/Gbb heterodimers induce high levels of signaling, respectively, through Tkv/Sax heterodimers ([@bib8]; [@bib53]). Comparison of the *gbb* mutant phenotypes in the midgut with those caused by *Pngl* loss and by *dpp* KD indicates that Dpp homodimers are the only productive form of ligand in PS7. Moreover, mesodermal KD of *tkv* severely decreases BMP signaling in PS7, but mesodermal KD of *sax* not only does not decrease pMad staining in PS7, but also results in an expansion of pMad expression domain in the PS7 region, similar to *gbb* mutant embryos. Together, these observations strongly support the notion that the BMP autoregulatory loop in the VM, which is essential for the activation of BMP signaling in the endoderm, relies solely on Dpp and Tkv homodimers, and therefore is impaired in *Pngl* mutants due to the severe decrease in the level of Dpp homodimers in these animals.

Vertebrate and invertebrate BMP proteins and other members of the TGFβ superfamily each harbor several *N*-linked glycosylation sites, which have been shown to be glycosylated in many cases ([@bib26]; [@bib47]; [@bib72]). Various functional roles have been ascribed to *N*-glycans on these ligands, including enhancing receptor binding of BMP6 ([@bib60]), keeping the TGFβ1 ligand in a latent state ([@bib47]), and promoting inhibin (α/β) heterodimer formation at the expense of activin (β/β) homodimer formation ([@bib3]). Accordingly, given the significant increase in Dpp monomeric forms and the simultaneous decrease in Dpp dimers upon loss of *Pngl*, it is possible that Pngl removes one or more *N*-glycans from Dpp and thereby promotes the formation or the stability of Dpp homodimers. Whether the regulation of Dpp by Pngl is direct or mediated via other proteins will remain to be explored.

In agreement with a previous report ([@bib46]), our data suggest that the lethality of *Pngl* mutants cannot be fully explained by shortening of the gastric caeca and impairment of BMP signaling in midgut development. *Pngl* KD with mesodermal drivers leads to a higher degree of lethality compared to *dpp* KD with the same drivers. Moreover, *how^24B^ \> Pngl^RNAi^* animals show \~70% lethality, even though they do not have gastric caeca defects. Finally, restoring BMP signaling in the midgut by expressing *tkvCA* only recues the lethality in \~30% of *Pngl^--/--^* animals. Phenotypic analysis of *Pngl* mutants combined with rescue and KD experiments suggest that a failure to properly empty the gut before puparium formation contributes to lethality in these animals. The molecular mechanisms for the food accumulation phenotype and other potential *Pngl^--/--^* phenotypes contributing to lethality are still under investigation.

In summary, our work indicates that the fly Pngl is an evolutionarily conserved *N*-glycanase enzyme necessary to sustain BMP autoactivation in the VM mediated by para-autocrine activity of Dpp homodimers through Tkv homodimers. Although we cannot exclude that Pngl plays important roles in other cell types as well, our data indicate that Pngl is primarily required in the mesoderm during midgut development and its loss results in Dpp-dependent and Dpp-independent midgut defects. Given the reports on potential para-autocrine functions of mammalian Dpp homologs ([@bib25]; [@bib58]; [@bib62]; [@bib74]) and prominent human pathologies associated with dysregulated BMP signaling in ophthalmic, gastrointestinal and musculoskeletal systems ([@bib78]), tissue-specific alterations in BMP signaling might contribute to some of the NGLY1 deficiency phenotypes including retinal abnormalities, delayed bone age and osteopenia, small feet and hands, and chronic constipation ([@bib22]; [@bib39]). Finally, understanding the mechanisms underlying the food accumulation phenotype in *Pngl^--/--^* larvae might shed light on the pathophysiology of chronic constipation in NGLY1 deficiency patients.

Materials and methods {#s4}
=====================

*Drosophila* strains and genetics {#s4-1}
---------------------------------

Animals were grown on standard food containing cornmeal, molasses and yeast at room temperature, except for RNAi crosses, which were cultured at 30°C. The following strains were used in this study: *y w*, *w; L/CyO, kr-GAL4 UAS-GFP* (*CyO-GFP*), *TM3, Sb^1^/TM6, Tb^1^*, *Act-GAL4*, *Mef2-GAL4*, *how^24B^-GAL4* ([@bib12]; [@bib66]), *dpp^10638^* (*dpp-lacZ*) ([@bib81]), *dpp^s2^* ([@bib46]), *UAS-dpp-GFP* ([@bib73]), *UAS-dpp^RNAi^* ([@bib44]), *UAS-tkv^RNAi^*, *gbb^D4^* and *gbb^D20^* ([@bib16]), *UAS-tkv^CA^* ([@bib1]), *Df(2R)ED1484*, *UAS-CD8::GFP* (Bloomington *Drosophila* Stock Center), *Pngl^ex14^*, *Pngl^ex18^*, *Pngl^ex20^*, *UAS-Pngl* and *UAS-Pngl-C303A* ([@bib23])*, NP3207-GAL4* and *NP3270-GAL4* ([@bib71]) (Kyoto *Drosophila* Stock Center), *UAS-Pngl^RNAi^* KK101641, *UAS-sax^RNAi^* (Vienna *Drosophila* Resource Center), *UAS-attB-NGLY1-WT-VK31* and *UAS-attB-NGLY1-ΔR402-VK31* (this study).

To identify homozygous animals in sibling crosses, *Pngl* and *gbb* mutants were balanced over a *CyO, kr-GAL4 UAS-GFP* chromosome. To examine *dpp* transcription in a *Pngl^--/--^* background, a *dpp-lacZ Pngl^ex14^/CyO-GFP* recombinant strain was generated and crossed to *Pngl^ex14^/CyO* GFP animals. To overexpress NGLY1 in *Pngl^--/--^* animals, *Pngl^--^* (*ex14* or *ex18*)*/CyO; GAL4* (*Actin, Mef2* or *how^24B^*)*/TM6, Tb^1^* animals were crossed to *Pngl^--^/CyO; UAS-attB-NGLY1-VK31* (*WT* or *ΔR402*)*/TM6, Tb^1^* animals. To overexpress Tkv^CA^ or Dpp-GFP in a *Pngl^--/--^* background, *Pngl^ex14^/CyO-GFP; Mef2-GAL4* animals were crossed to *Pngl^ex14^/CyO-GFP; UAS-tkv^CA^* (or *UAS-dpp-GFP*) and absence of the *CyO-GFP* was used to select the intended genotype. To overexpress Pngl and Pngl-C303A in *Pngl^--/--^* animals, *Pngl^ex14^/CyO-GFP; Mef2-GAL4* animals were crossed to *Pngl^ex14^/CyO-GFP; UAS-Pngl and Pngl^ex14^/CyO-GFP; UAS-Pngl-C303A* animals and selected similar to the above crosses.

Survival, longevity, and fertility assays {#s4-2}
-----------------------------------------

For survival (eclosion) tests, the expected ratio of offspring was calculated based on Mendelian inheritance for each genotypic class and the observed/expected ratio is reported as a percentage. Fertility was assessed by placing 2-day-old single male of each genotype with three 4-day-old virgin *y w* females or three 4-day-old virgin females of each genotype with three 4-day-old virgin *y w* males. Flies were transferred to fresh vials every 5 days for three times. The total number of progeny produced over 20 days by each animal was counted. Data are represented as mean ±SD of 3 independent sets of experiments. For longevity analyses, newly eclosed males of each genotype were collected and housed at a density of 5 flies per vial. Flies were transferred to fresh food every 3--4 days, and dead flies were counted every day until all died. Data are represented as mean of 3 independent sets of experiments.

Generation of NGLY1 overexpression transgenes {#s4-3}
---------------------------------------------

Human *NGLY1* cDNA in *pCMV6-AC* vector (clone SC320763, OriGene) was used as template for site-directed mutagenesis to introduce the c.1205_1207del clinical mutation ([@bib22]), which results in the generation of NGLY1-ΔR402. Wild-type and ΔR402 cDNAs were transferred from *pCMV6-AC* to *pUAST-attB* vector by *EcoRI-XhoI* double digestion and ligation, verified by sequencing, and integrated into the *VK31* docking site by ΦC31-mediated transgenesis ([@bib10]; [@bib76]).

Gut clearance assay and visualization of the acid zone {#s4-4}
------------------------------------------------------

Larvae were raised on standard food supplemented with 0.05% bromophenol blue (BPB). Wandering larvae were collected from the side of the vial with a wet paint brush, transferred to a petri dish lined with wet Whatman paper and monitored for gut clearance until puparium formation. About 30 larvae were scored for each genotype at each time point. Each data point is from three independent experiments. For larval gut acidification studies, 72 hours after egg deposition, larvae were transferred to standard food containing 0.05% BPB and dissected after 12 hours. For examination of adult acid zones, one-day old animals were fed on food supplemented with 0.05% BPB for two days and then dissected. The images were taken by ToupCam Camera and analyzed by ToupView software.

RTL spotting assay {#s4-5}
------------------

RTL spotting assay was carried out using *png1Δ* cells (*png1::KanMX4 Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0)* and pRS313-~GAL4~RTL essentially as described previously ([@bib45]). In brief, strains harboring the RTL expression plasmid were spotted on to SC-histidine-uracil or SC-histidine-uracil-leucine medium containing 2% galactose (w/v), and plates were incubated at 30°C for 3 days. Photographs of the plates were taken using FUJIFILM LAS-3000 mini (Fujifilm Co., Tokyo, Japan).

Cycloheximide decay assay {#s4-6}
-------------------------

*png1Δ* cells harboring the pRS315-~GPD~FLAG-RTAΔ ([@bib32]) were grown at 30°C in SC-leucine liquid medium. Cycloheximide was added at t = 0 min (final concentration, 4 μg/ml), and the samples were collected at the indicated times and subjected to SDS-PAGE, followed by immunoblotting with anti-DYKDDDDK antibody 1:10,000 (Wako Cat\# 018--22381, RRID:[AB_10659453](https://scicrunch.org/resolver/AB_10659453)). Phosphoglycerate kinase (Pgk1) was used as a loading control and was probed with anti-Pgk1 antibody 1:10,000 (Molecular Probes Cat\# A-6457, RRID:[AB_221541](https://scicrunch.org/resolver/AB_221541)).

Western blotting {#s4-7}
----------------

Proteins were extracted from whole larvae in lysis buffer containing protease inhibitor cocktail (Promega). The following antibodies were used: rabbit anti-NGLY1 1:500 (Sigma-Aldrich Cat\# HPA036825, RRID:[AB_10672231](https://scicrunch.org/resolver/AB_10672231)), mouse anti-tubulin 1:1000 (Santa Cruz Biotechnology Cat\# sc-8035, RRID:[AB_628408](https://scicrunch.org/resolver/AB_628408)), mouse anti-actin 1:1000 (DSHB Cat\# 224-236-1, RRID:[AB_10571933](https://scicrunch.org/resolver/AB_10571933)), rabbit anti-Pngl 1:250 ([@bib23]), rabbit anti-Dpp 1:1000 ([@bib2]), mouse anti-HA 1:20,000 (Sigma-Aldrich Cat\# B9183, RRID:[AB_439706](https://scicrunch.org/resolver/AB_439706)), goat anti-rabbit-HRP and goat anti-mouse-HRP 1:2000 (Jackson ImmunoResearch Laboratories). Western blots were developed using Pierce ECL Western Blotting Substrates (Thermo Scientific). The bands were detected using an ImageQuant LAS 4000 system from GE Healthcare. At least three independent immunoblots were performed for each experiment.

Immunostaining {#s4-8}
--------------

The following antibodies were used: rabbit anti-pSMAD3 1:250 (Abcam Cat\# ab52903, RRID:[AB_882596](https://scicrunch.org/resolver/AB_882596)), guinea pig anti-Labial 1: 1000 ([@bib27]), rabbit-anti Dpp 1:100 ([@bib2]), mouse anti-βGAL 1:50 (DSHB Cat\# 40-1a, RRID:[AB_528100](https://scicrunch.org/resolver/AB_528100)), mouse anti-Fas3 1:50 (DSHB Cat\# 7G10 anti-Fasciclin III, RRID:[AB_528238](https://scicrunch.org/resolver/AB_528238)), mouse anti-GFP 1:500 (Thermo Fisher Scientific Cat\# 33--2600, RRID:[AB_2533111](https://scicrunch.org/resolver/AB_2533111)), goat anti-rabbit-Cy3 1:500, goat anti-mouse-Cy5 1:500 (Jackson ImmunoResearch Laboratories). Confocal images were taken with Leica TCS-SP8 microscope. All images were acquired using Leica LAS-SP software. Amira 5.2.2 and Adobe Photoshop CS6 were used for processing and Figures were assembled in Adobe Illustrator CS6.
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Decision letter

VijayRaghavan

K

Reviewing Editor

National Centre for Biological Sciences, Tata Institute of Fundamental Research

India

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Tissue-specific regulation of BMP signaling by *Drosophila* N-glycanase 1\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by K VijayRaghavan as the Senior Editor and Reviewing Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this manuscript, the authors investigate the role of the *pngl* gene (which encodes an enzyme that removes N-linked glycans) during *Drosophila* development. This study is highly relevant as mutations in the human ortholog of this gene (NGLY1) are responsible for a congenital disorder of glycosylation where patients present with major developmental delays. Using genetic deficiencies, deletions and RNAi interference, the authors identify a role for this gene in Dpp signaling during early development that results in phenotypic abnormalities in larvae. Specifically, they demonstrate that loss of *pngl* influences the extent of Dpp propagation in PS3 and PS7 of embryonic development, thereby affecting mesoderm to endoderm signaling. This study is thorough, well-controlled and will provide important insights into signaling pathways and cellular mechanisms that may be responsible for the phenotypes observed in human NGLY1 patients.

This study does represent an important step in understanding how the loss of this gene influences a particular signaling pathway during a stage of development and could be very useful in beginning to interpret some of the developmental defects occurring in the patients. It would be very informative to know if (and how) the glycosylation status of *dpp* is altered upon loss of *pngl,* but we do see that is beyond the scope of the current study.

Please use the specific comments from the reviewers, some overlapping, to submit a revised manuscript.

Essential revisions:

*Comments of Reviewer \#1:*

The overall concerns with the manuscript at this point are some of the interpretations and lack of biochemical mechanistic insight into the link between N-glycanase activity and Dpp homodimerization.

1\) Why are *Pngl* mutants lethal? Mutants that lead to loss of the Copper cell region do not result in lethality (Cell Tissue Res. 2001 Oct: 306(1): 167-78). *how-Gal4* driven knockdown also results in lethality but does affect gastric caeca formation. This suggests that lethality is not due to loss of the caeca.

2\) *Mef2-Gal4* and *how-Gal4* expression of human NGLY1 partially rescues *Pngl* lethality. *Mef2-Gal4* and *how-Gal4* expression of *Pngl* RNAi results in 0 and 28% survivability and *Mef2-Gal4* and *how-Gal4* expression of *dpp* RNAi results in loss of the acid region and caeca and 8 and 80% survivability, leading the authors to conclude that *Pngl* plays a *dpp* independent role. This may indeed be the case and should be mentioned in the Abstract. However, an alternative explanation is that *dpp* is required in other tissues and the knockdown by these drivers is not effective in the other tissues.

3\) Subsection "Loss of BMP signaling in *Pngl^--/--^* embryonic endoderm is caused by impaired BMP autoactivation in VM": *Mef\>tkv^CA^* rescues *Pngl* lethality. Given the concerns that lethality is not due to caeca or acid region loss, this would argue that *Pngl* is required for BMP/ (maybe TGF-B) signaling elsewhere.

4\) Do *Mef\>tkv^CA^ Pngl* minus flies that make it to adulthood have a Copper cell region. It would be interesting to know if *Pngl* is required for proper midgut formation during metamorphosis.

5\) Mutants that make it to adulthood are sterile. Do these animals have ovaries/testis that are consistent with loss of *dpp*, i.e. germline stem cell loss? Knowing this might help to establish *Pngl* as a gene required for a subset of BMP signaling pathway events. It would especially be interesting as *gbb* is also required for germline stem cell maintenance.

6\) From the Abstract, the authors write,\"\[...\]without affecting BMP signaling in other contexts\[...\]\" It\'s impossible to be sure it is not affecting BMP signaling in other contexts. It\'s just that the authors were not able to identify any others. The same concern relates to the last sentence of the subsection "BMP signaling from VM to endoderm is impaired upon loss of *Pngl*". The word \"specifically\" should be removed.

7\) Do *Pngl* genes harboring a C303A mutation fail to rescue the *Pngl* mutant fly phenotypes. This would at least genetically link the catalytic domain/activity to described phenotypes. There is no data in this paper to how *Pngl* affects *dpp*.

8\) Why did the authors, in [Figure 6](#fig6){ref-type="fig"}, do Western Blots on whole larvae and not midguts versus carcass (midgut minus)? Changes in dimmer accumulation in carcass could help identify other tissues where *Pngl* may act.

9\) \"BMP ligands can signal both as homodimers and as heterodimers (Bragdon et al., 2011; 383 O\'Connor et al., 2006).\"

If so, have the authors examined the tissues where the ligands act as homodimers? Do they have phenotypes? Changes in accumulation on Western Blots?

*Comments of Reviewer \#2:*

1\) As the mesodermal knockdown of *pngl* was more severe that the knockdown of *dpp*, can the authors comment on reasons for this (are there other suspected targets of *Pngl* in the mesoderm)?

2\) Clarification with regard to rescue experiments-is Dpp-GFP processed and dimerized in the same manner as endogenous Dpp? Does it have the same N-glycans? If not, could this affect your interpretation (or perhaps give clues as to what region of Dpp is affected by *Pngl*)?

3\) In *pngl* mutants, can you distinguish between Dpp protein simply being produced at a lower level (due to instability, higher turnover, etc.) vs. Dpp protein not being able to mediate autoregulation? Or are these different ways of saying the same thing?

4\) Can the authors comment on whether any of the major phenotypes seen in the NGLY1 patients are thought to be due to changes in BMP signaling?

10.7554/eLife.27612.021

Author response

*Essential revisions:*

*Comments of Reviewer \#1:*

> The overall concerns with the manuscript at this point are some of the interpretations and lack of biochemical mechanistic insight into the link between N-glycanase activity and Dpp homodimerization.
>
> 1\) Why are Pngl mutants lethal? Mutants that lead to loss of the Copper cell region do not result in lethality (Cell Tissue Res. 2001 Oct: 306(1): 167-78). how-Gal4 driven knockdown also results in lethality but does affect gastric caeca formation. This suggests that lethality is not due to loss of the caeca.

We thank the reviewer for raising this important point. Mutants with loss of acid zone usually do not show lethality. Moreover, our data indicate that *dpp* knockdown by *how-GAL4*, which is expressed after gastric caeca anlagen is formed, does not lead to significant lethality. This is not true in *how-GAL4*-mediated *Pngl* knockdown experiments, where the lethality is remarkably high although gastric caeca formation is not affected. Therefore, although we think gastric caeca shortening contributes to *Pngl* lethality (please see below), these data clearly suggest that other events are involved in the lethality of *Pngl* mutants. At the time of the original submission, we had data showing a Dpp-independent midgut phenotype (food accumulation) in *Pngl* mutant and mesoderm-specific knockdown larvae. However, we decided not to include the data in the first version because we do not know the molecular mechanism for this phenotype, and the manuscript was focused on BMP signaling. Since both reviewers have inquired about the reason behind the discrepancy between *dpp* knockdown and *Pngl* mutant/knockdown phenotypes, we now include the data in the revised [Figure 4](#fig4){ref-type="fig"}. *Pngl*-mutant wandering larvae accumulate food in the midgut and are not able to properly empty their midgut before puparium formation. Comparing knockdown data for *dpp* and *Pngl* by pan-mesodermal drivers reveals that the food accumulation phenotype in *Pngl* larvae is at least in part and perhaps fully independent of impairment in BMP signaling. Specifically, *how\>dpp^RNAi^* larvae do not show any food accumulation phenotype, but *how\>Pngl^RNAi^* larvae show a rather severe food accumulation phenotype. It is noteworthy that *Mef2\>dpp^RNAi^* larvae show some degree of food accumulation. This phenotype is milder than that observed in *Mef2\>Pngl^RNAi^* larvae and *Pngl* mutants, and might be due to defects caused by complete loss of Dpp in the mesoderm, independently of the function of *Pngl*. Nevertheless, in the manuscript we call the food accumulation phenotype partially independent from Dpp signaling to be on the safe side.

By studying several alleles of *dpp* which specifically affect its expression in PS3 and PS7 in the embryonic visceral mesoderm, the Hoffmann group showed that loss of gastric caeca is accompanied by developmental delay and some degree of larval and pupal lethality (Masucci and Hoffmann, 1993). In agreement with this report, we believe our data indicate that shortening of gastric caeca contributes to the lethality of *Pngl* mutants. As shown in the original [Figure 5](#fig5){ref-type="fig"} (revised [Figure 6](#fig6){ref-type="fig"}), overexpression of TkvCA restores BMP signaling in *Pngl* mutant embryonic midgut and rescues the lethality of *Pngl* mutants around 30%. Moreover, the rescue of *Pngl* mutant lethality by *how\>NGLY1* is weaker than the rescue with *Mef2\>NGLY1* (revised [Figure 3J](#fig3){ref-type="fig"}). Lastly, \~30% of *how\>Pngl^RNAi^*animals reach adulthood, even though they lose the acid zone and show food accumulation. We conclude that the lethality of *Pngl* mutants arises from at least two sources: to some extent from BMP-dependent defects in the midgut (mostly due to the gastric caeca shortening), to a larger extent from BMP-independent defects in the mesoderm, and potentially due to minor contributions from non-mesodermal tissues. The importance of the structural and functional integrity of visceral mesoderm in *Drosophila* larvae is an understudied area. Among the small number of studies that we found discussing the importance of visceral mesoderm, one of them seems to show a correlation between a failure to empty the gut due to functional defects in visceral mesoderm and lethality (Bland et al., 2010). Unfortunately, our current data do not allow us to draw strong conclusions on the extent to which the food accumulation phenotype contributes to the lethality of *Pngl* larvae. We have used the following sentences in the revised Discussion to convey this message: "Phenotypic analysis of *Pngl* mutants combined with rescue and KD experiments suggest that a failure to properly empty the gut before puparium formation contributes to lethality in these animals. The molecular mechanisms for the food accumulation phenotype and other potential *Pngl^--/--^*phenotypes contributing to lethality are still under investigation."

> 2\) Mef2-Gal4 and how-Gal4 expression of human NGLY1 partially rescues Pngl lethality. Mef2-Gal4 and how-Gal4 expression of Pngl RNAi results in 0 and 28% survivability and Mef2-Gal4 and how-Gal4 expression of dpp RNAi results in loss of the acid region and caeca and 8 and 80% survivability, leading the authors to conclude that Pngl plays a dpp independent role. This may indeed be the case and should be mentioned in the Abstract. However, an alternative explanation is that dpp is required in other tissues and the knockdown by these drivers is not effective in the other tissues.

In the revised version, we mention the issue raised by the reviewer in the Abstract as well as in Results and Discussion. As discussed above, we now present evidence for a food accumulation phenotype in *Pngl* mutant and mesodermal KD animals that is at least partially Dpp-independent. Given that overexpression of NGLY1 in the mesoderm of *Pngl* mutants results in the formation of adults at greater than 80% of the Mendelian ratio, *Pngl* seems to be primarily required in the mesoderm during fly development. Having said that, the reviewer's point is well taken: our data are not sufficient to rule out a role for *Pngl* in non-mesodermal tissues. Accordingly, we have added the following phrase to the last paragraph of the Discussion: "Although we cannot exclude that *Pngl* might play important roles in other cell types as well, our data indicate that *Pngl* is primarily required in the mesoderm during midgut development\[...\]"

> 3\) Subsection "Loss of BMP signaling in Pngl^--/--^ embryonic endoderm is caused by impaired BMP autoactivation in VM": Mef\>tkv^CA^ rescues Pngl lethality. Given the concerns that lethality is not due to caeca or acid region loss, this would argue that Pngl is required for BMP/ (maybe TGF-B) signaling elsewhere.

As explained above, our data indicate that gastric caeca shortening most likely contributes to lethality, in agreement with a previous report (Masucci and Hoffmann, 1993). Therefore, we believe that the partial rescue of *Pngl* lethality by *Mef2*\>tkvCA can be explained by the rescue of gastric caeca. However, we agree with the reviewer that it is possible that *Pngl* is required in other contexts for TGF-β or BMP signaling during embryonic or larval development. Accordingly, we have modified the Results section as follows: "These observations further indicate that impaired BMP signaling is partially responsible for the lethality of *Pngl^--/--^* animals. This is likely due to gastric caeca shortening (Masucci and Hoffmann, 1993), although we cannot exclude that *tkvCA* overexpression affects unknown BMP-related defects in other parts of mesoderm in these mutants."

> 4\) Do Mef\>tkv^CA^ Pngl minus flies that make it to adulthood have a Copper cell region. It would be interesting to know if Pngl is required for proper midgut formation during metamorphosis.

To address this point, we have investigated the adult midgut of *Pngl* escapers and compared them with flies rescued by overexpressing *tkvCA* with *Mef2-GAL4.* As shown in the revised [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}, *tkvCA* rescues the adult Copper cell region and the midgut length in *Pngl* mutants.

> 5\) Mutants that make it to adulthood are sterile. Do these animals have ovaries/testis that are consistent with loss of dpp, i.e. germline stem cell loss? Knowing this might help to establish Pngl as a gene required for a subset of BMP signaling pathway events. It would especially be interesting as gbb is also required for germline stem cell maintenance.

To address this point, we have tested whether loss of *Pngl* causes impairment of BMP signaling in germline stem cells (GSCs) of ovaries and testes in *Pngl* adult escapers 3-4 days after eclosion (n\>10 for each). We have stained both tissues by pMad antibody to test BMP signaling and Vasa antibody to mark germline cells and their progeny. Our data suggest that BMP signaling in germaria of *Pngl* mutant ovaries is not lost, as we see pMad co-localized with Vasa in the anterior part of the germarium. Unfortunately, we cannot test GSC maintenance and BMP signaling in an age-dependent manner in mutant germaria of *Pngl* adult escapers due to their short lifespan. Notably, we have found a severe decrease in pMad expression in the anterior part of the mutant testis in male *Pngl* adult escapers, strongly suggesting BMP signaling impairment in this tissue. These data indicate that the reviewer is correct: although among the BMP-dependent processes during embryonic and larval stages that we have studies so far midgut development is the only context affected by the loss of *Pngl, Pngl* is likely to have important roles in some additional cell types as well. We have modified the revised version to reflect this notion, as mentioned in our response to questions 3 and 4. However, we feel that it's premature to add the testis and ovary data to the manuscript, as both tissues also show morphological abnormalities that are not likely to be caused by the loss of BMP signaling. We will need to perform additional in-depth studies on these tissues to bring them to the same level of scrutiny applied in our midgut studies, and the manuscript is already somewhat long, especially after the addition of food accumulation data. We hope that the editor and reviewer will agree with our strategy of not showing the ovary/testis data but clearly mentioning that specific cell types other than visceral mesoderm are likely to require the function of *Pngl* as well.

> 6\) From the Abstract, the authors write,\"\[...\]without affecting BMP signaling in other contexts\[...\]\" It\'s impossible to be sure it is not affecting BMP signaling in other contexts. It\'s just that the authors were not able to identify any others. The same concern relates to the last sentence of the subsection "BMP signaling from VM to endoderm is impaired upon loss of Pngl". The word \"specifically\" should be removed.

We agree with the reviewer and have modified the text to address this issue in the Abstract and the Results section and removed "specifically".

> 7\) Do Pngl genes harboring a C303A mutation fail to rescue the Pngl mutant fly phenotypes. This would at least genetically link the catalytic domain/activity to described phenotypes. There is no data in this paper to how Pngl affects dpp.

This was a great suggestion (like a number of other points raised by the reviewer). As shown in new panels in the revised [Figure 3 (3K-3O](#fig3){ref-type="fig"}), transgenic overexpression of *Pngl* harboring a single mutation in its catalytic domain (C303A) in the mesoderm of *Pngl* mutants failed to rescue the gastric caeca length and the acid zone, even though Western blots show that this mutation does not affect the expression level of Pngl. In contrast, overexpression of wild-type Pngl by the same driver (*Mef2*-GAL4) fully rescued these phenotypes. These data indicate that *Pngl*'s deglycosylation activity is essential for the regulation of BMP pathway in larval midgut.

> 8\) Why did the authors, in [Figure 6](#fig6){ref-type="fig"}, do Western Blots on whole larvae and not midguts versus carcass (midgut minus)? Changes in dimmer accumulation in carcass could help identify other tissues where Pngl may act.

To address this issue, we have performed carcass vs. midgut Western Blot in a non-reducing condition and probed with Dpp antibody. As shown in [Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}, the level of Dpp dimer is decreased not only in the midgut but also in other parts of the larval body. This could mean that either *Pngl* regulates BMP signaling by affecting Dpp dimer levels in other larval tissues, or that Dpp dimers are only important in the midgut and although they are decreased elsewhere, Dpp-Gbb heterodimers compensate for the lack of Dpp dimers in most other tissues. We have discussed both of these possibilities in the revised version (Discussion).

> 9\) \"BMP ligands can signal both as homodimers and as heterodimers (Bragdon et al., 2011; 383 O\'Connor et al., 2006).\"
>
> If so, have the authors examined the tissues where the ligands act as homodimers? Do they have phenotypes? Changes in accumulation on Western Blots?

Cell-based assays have indicated that BMP ligands can signal both as homodimers and heterodimers. However, the relative in vivo contribution of BMP heterodimer versus homodimer in most tissues is not well known. Therefore, unfortunately we do not have the knowledge required to address the reviewer's comment.

*Comments of Reviewer \#2:*

> 1\) As the mesodermal knockdown of pngl was more severe that the knockdown of dpp, can the authors comment on reasons for this (are there other suspected targets of Pngl in the mesoderm)?

We thank the reviewer for raising this point. As described in our response to questions 1-3 of reviewer 1, we have added a new figure (revised [Figure 4](#fig4){ref-type="fig"}) to address this issue. Unfortunately, we do not know the target(s) of *Pngl* involved in this phenotype, as it seems to be mostly BMP-independent.

> 2\) Clarification with regard to rescue experiments-is Dpp-GFP processed and dimerized in the same manner as endogenous Dpp? Does it have the same N-glycans? If not, could this affect your interpretation (or perhaps give clues as to what region of Dpp is affected by Pngl)?

To clarify this point, we overexpressed *dpp-GFP* by *Mef2-GAL4* and tested the Dpp pattern by anti-GFP Western blotting in reducing and non-reducing conditions. As previously reported in S2 cells (Teleman and Cohen, 2000), we found that the precursor and mature forms of Dpp-GFP match the expected size and pattern in reducing conditions (Author response [Figure 1](#fig1){ref-type="fig"}, left lane). In addition, in non-reducing conditions the size of the observed bands corresponds to Dpp-GFP dimers, and they show the same pattern as the endogenous Dpp (Author response [Figure 1](#fig1){ref-type="fig"}, right lane). These data suggest that the GFP polypeptide which has been inserted in Dpp protein does not affect its processing and dimerization. Moreover, we have checked the GFP sequence inserted in Dpp by consulting the Experimental Procedures of the paper which reported the generation of this transgene (Teleman and Cohen, 2000) and looked for potential *N*- glycosylation consensus sequences (N-X-S/T). None of the 13 asparagine residues present in this fragment conforms to the *N*-glycosylation consensus sequence. Since the GFP has been inserted in the context of the full length Dpp (without any deletions in the Dpp protein), the Dpp-GFP protein most likely possesses the same *N*-glycans as the endogenous Dpp.

![Dpp-GFP shows dimerization and processing patterns similar to Dpp.\
Larval extracts from *Mef2\>dpp-GFP*were run under reducing (left lane) and non-reducing (right lane) conditions and probed with an anti-GFP antibody.](elife-27612-resp-fig1){#respfig1}

> 3\) In pngl mutants, can you distinguish between Dpp protein simply being produced at a lower level (due to instability, higher turnover, etc.) vs. Dpp protein not being able to mediate autoregulation? Or are these different ways of saying the same thing?

Four observations in the original manuscript were used to conclude that Dpp autoregulation in the visceral mesoderm is impaired: presence of initial, Ubx-dependent expression of *dpp* in stage 13 *Pngl* embryos, lack of pMad in the visceral mesoderm of these embryos, rescue of pMad expression in endoderm by mesodermal overexpression of Dpp-GFP, and rescue of pMad expression in the endoderm by overexpression of TkvCA in the mesoderm. We believe that it is difficult to reconcile the hypothesis of a simple reduction in Dpp as the cause of these phenotypes with the last line of evidence mentioned here. However, the reviewer's comment prompted us to test whether reducing the *dpp* expression in mesoderm by another strategy could impair BMP autoregulation. The *dpp^S2^* allele harbors a chromosomal breakpoint in regulatory elements that control *dpp* expression in the visceral mesoderm and results in a complete loss of *dpp* expression in the visceral mesoderm in homozygosity, without affecting its expression in other embryonic tissues (Masucci and Hoffmann, 1993). We reasoned that if decreasing Dpp production levels is sufficient to explain the *Pngl* midgut phenotypes, animals heterozygous for this allele, which will presumably lose 50% of *dpp* expression in the visceral mesoderm, should show defects in the propagation of the Dpp expression domain and expression of pMad in embryonic midgut and potentially some BMP-dependent defects in the larval midgut. As the new panels in the revised [Figure 5 (M and N](#fig5){ref-type="fig"}) show, in stage 13 *dpp^S2^* heterozygous embryos, the level of Dpp protein in PS7 is even less than that Dpp level in *Pngl* homozygous embryos. However, it can lead to Dpp spreading at stage 14. Moreover, as shown in a new supplemental figure of [Figure 5](#fig5){ref-type="fig"}, *dpp^S2^* heterozygous animals do not exhibit defects in the formation of second midgut compartment and Labial expression in the embryo and in the acid zone in third instar larvae. These observations further support the conclusion that impairment of the Dpp autoregulatory loop underlies the loss of BMP signaling in *Pngl* mutant midguts.

> 4\) Can the authors comment on whether any of the major phenotypes seen in the NGLY1 patients are thought to be due to changes in BMP signaling?

We have added some sentences to the last paragraph of the Discussion section to address this issue.
